Induction of experimental autoimmune encephalomyelitis by CD4+ T cells specific for an astrocyte protein, Sl00ß

[1]  T. Olsson,et al.  The major histocompatibility complex influences myelin basic protein 63‐88‐induced T cell cytokine profile and experimental autoimmune encephalomyelitis , 1993, Journal of Neuroimmunology.

[2]  F. Michetti,et al.  S-100 protein in rat brown adipose tissue under different functional conditions: a morphological, immunocytochemical, and immunochemical study. , 1993, Experimental cell research.

[3]  H. Lassmann,et al.  T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system , 1993, European journal of immunology.

[4]  C. Janeway,et al.  Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma , 1993, The Journal of experimental medicine.

[5]  R. D. Simmons,et al.  Sialyl ligands facilitate lymphocyte accumulation during inflammation of the central nervous system , 1992, Journal of Neuroimmunology.

[6]  T. Mak,et al.  Less Mortality but More Relapses in Experimental Allergic Encephalomyelitis in CD8-/- Mice , 1992, Science.

[7]  J. Pepose,et al.  Immunopathologic features of retinal lesions in multiple sclerosis. , 1991, Ophthalmology.

[8]  B. Uitdehaag,et al.  Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages , 1990, The Journal of experimental medicine.

[9]  L. Hood,et al.  Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies , 1990, The Journal of experimental medicine.

[10]  D. Carlo,et al.  Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. , 1989, Science.

[11]  E. Sercarz,et al.  Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. , 1989, Cellular immunology.

[12]  A. Vandenbark,et al.  Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis , 1989, Nature.

[13]  R. Donato,et al.  Immunocytochemical localization of S-100b protein in degenerating and regenerating rat sciatic nerves. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[14]  H. Wekerle,et al.  T cell receptor β chain usage in myelin basic protein‐specific rat T lymphocytes , 1989 .

[15]  N. Shen,et al.  Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different , 1989, The Journal of experimental medicine.

[16]  A. Ben-nun,et al.  Regulatory circuits in autoimmunity: recruitment of counter‐regulatory CD8+ T cells by encephalitogenic CD4+ T line cells , 1988, European journal of immunology.

[17]  L. Hood,et al.  Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy , 1988, Cell.

[18]  H. Mcdevitt,et al.  Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention , 1988, Cell.

[19]  I. Cohen,et al.  Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. , 1988, Science.

[20]  L. V. Eldik,et al.  Secretion of S-100 from rat C6 glioma cells , 1987, Brain Research.

[21]  T. Yoshino,et al.  S-100 beta positive human T lymphocytes: their characteristics and behavior under normal and pathologic conditions. , 1987, Blood.

[22]  W. Mcdonald,et al.  Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. , 1987, Brain : a journal of neurology.

[23]  K. Araki,et al.  Tissue distribution of rat S-100α and β subunit mRNAs , 1987 .

[24]  D. Zimmer,et al.  Tissue distribution of rat S100 alpha and S100 beta and S100-binding proteins. , 1987, The American journal of physiology.

[25]  P. Ince,et al.  Chronic periphlebitis retinae in multiple sclerosis A histopathological study , 1987, Journal of the Neurological Sciences.

[26]  T. Tabira,et al.  Passive transfer of experimental allergic encephalomyelitis induced by proteolipid apoprotein , 1986, Journal of the Neurological Sciences.

[27]  H. Wekerle,et al.  Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes , 1986, Nature.

[28]  I. Cohen,et al.  Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase , 1984, Nature.

[29]  B. Moore,et al.  Proteins of the Brain Extracellular Fluid: Evidence for Release of S‐100 Protein , 1984, Journal of neurochemistry.

[30]  H. Webster,et al.  Immunocytochemical localization of basic protein in major dense line regions of central and peripheral myelin , 1982, The Journal of cell biology.

[31]  R. Wollmann,et al.  Distribution of S-100 protein outside the central nervous system , 1982, Brain Research.

[32]  I. Cohen,et al.  Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein , 1981, Nature.

[33]  C. Brosnan,et al.  The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. , 1981, Journal of immunology.

[34]  I. Leopold,et al.  The incidence of uveitis in multiple sclerosis. , 1966, American journal of ophthalmology.

[35]  G. Schönrich,et al.  Multiple levels of peripheral tolerance. , 1993, Immunology today.

[36]  D. Willenborg,et al.  Lymphocytes utilise sialylated surface molecules to accumulate in developing lesions of autoimmune encephalomyelitis. , 1992, Autoimmunity.

[37]  D. McFarlin,et al.  Immunological aspects of demyelinating diseases. , 1992, Annual review of immunology.

[38]  H. Higley,et al.  Thymic interdigitating reticulum cells demonstrated by immunocytochemistry. , 1984, Thymus.